Management of complications of immunosuppressants |
Conferences
eMediNexus Coverage from: 
Management of complications of immunosuppressants
Dr Vinay Keshavamurthy, Chandigarh,  23 January 2019
Coronavirus Live Count Map India

remove_red_eye 719 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

Prevention better than cure:o  Identify patients at risk of adverse effectso  Baseline evaluationo  Regular clinical and laboratory monitoringo  Drugs: PPI, Folic acid.Most immunosuppressants can be safely administered in patients with HCV and occult HBV. Acute HBV infection requires treatment prior to immunosuppression.IGRA is the preferred screening method for latent tubercular infection among Indians. INH and RCIN treatment for at least 1 month prior to immunosuppression.A...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now